159 related articles for article (PubMed ID: 34344069)
41. Mesenchymal Chondrosarcoma-A Retrospective study.
Beena D; Kattoor J; Mathews A; P Nair S; M V; T P; N G
Gulf J Oncolog; 2021 Jan; 1(35):54-58. PubMed ID: 33716213
[TBL] [Abstract][Full Text] [Related]
42. [Clinicopathologic diagnosis of de-differentiated chondrosarcoma].
Huang J; Zhang HZ; Zheng L; Zhou J; Jiang ZM
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):820-3. PubMed ID: 20193457
[TBL] [Abstract][Full Text] [Related]
43. Intracranial mesenchymal chondrosarcoma: case report and literature review.
Kan Z; Li H; Zhang J; You C
Br J Neurosurg; 2012 Dec; 26(6):912-4. PubMed ID: 22731866
[TBL] [Abstract][Full Text] [Related]
44. Genomic profiling identifies genes and pathways dysregulated by HEY1-NCOA2 fusion and shines a light on mesenchymal chondrosarcoma tumorigenesis.
Qi W; Rosikiewicz W; Yin Z; Xu B; Jiang H; Wan S; Fan Y; Wu G; Wang L
J Pathol; 2022 Aug; 257(5):579-592. PubMed ID: 35342947
[TBL] [Abstract][Full Text] [Related]
45. Lack of Bcl10 mutations in malignant cartilaginous tumors.
Park YK; Park HR; Kim YW; Chi SG; Unni KK
Int J Mol Med; 2002 Mar; 9(3):217-9. PubMed ID: 11836626
[TBL] [Abstract][Full Text] [Related]
46. Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma.
Morioka H; Takahashi S; Araki N; Sugiura H; Ueda T; Takahashi M; Yonemoto T; Hiraga H; Hiruma T; Kunisada T; Matsumine A; Susa M; Nakayama R; Nishimoto K; Kikuta K; Horiuchi K; Kawai A
BMC Cancer; 2016 Jul; 16():479. PubMed ID: 27418251
[TBL] [Abstract][Full Text] [Related]
47. Rare malignant primary spinal intradural extramedullary mesenchymal chondrosarcoma: a case report and literature review.
Wang Y; Meng X; Liu W; Wang H; Xin T
Transl Cancer Res; 2022 Sep; 11(9):3371-3378. PubMed ID: 36237254
[TBL] [Abstract][Full Text] [Related]
48. Primary intra- and extradural extramedullary mesenchymal chondrosarcoma with isolated punctate calcification: case report and literature review.
Chen M; Lai Q
BMC Neurol; 2022 Mar; 22(1):112. PubMed ID: 35321663
[TBL] [Abstract][Full Text] [Related]
49. Mesenchymal chondrosarcoma of the orbit: imaging features of CT and MRI.
Tsuchiya M; Masui T; Otsuki Y; Sakahara H
Br J Radiol; 2018 Oct; 91(1090):20170579. PubMed ID: 29975155
[TBL] [Abstract][Full Text] [Related]
50. Patient-derived xenografts and in vitro model show rationale for imatinib mesylate repurposing in HEY1-NCoA2-driven mesenchymal chondrosarcoma.
Safaric Tepes P; Segovia D; Jevtic S; Ramirez D; Lyons SK; Sordella R
Lab Invest; 2022 Sep; 102(9):1038-1049. PubMed ID: 34837064
[TBL] [Abstract][Full Text] [Related]
51. Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups.
Dantonello TM; Int-Veen C; Leuschner I; Schuck A; Furtwaengler R; Claviez A; Schneider DT; Klingebiel T; Bielack SS; Koscielniak E; ;
Cancer; 2008 Jun; 112(11):2424-31. PubMed ID: 18438777
[TBL] [Abstract][Full Text] [Related]
52. Mesenchymal chondrosarcoma of the sellar region.
Inenaga C; Morii K; Tamura T; Tanaka R; Takahashi H
Acta Neurochir (Wien); 2003 Jul; 145(7):593-7; discussion 597. PubMed ID: 12910404
[TBL] [Abstract][Full Text] [Related]
53. Angiofibroma of Soft Tissue: A Clinicopathological Study of Eight Cases With Emphasis on the Diagnostic Utility of Fluorescence
Wang C; Fan Y; Wei J; Xu Q; Ru G; Zhao M
Front Oncol; 2022; 12():900411. PubMed ID: 35832542
[TBL] [Abstract][Full Text] [Related]
54. Mesenchymal chondrosarcoma of bone and soft tissues.
Bertoni F; Picci P; Bacchini P; Capanna R; Innao V; Bacci G; Campanacci M
Cancer; 1983 Aug; 52(3):533-41. PubMed ID: 6861090
[TBL] [Abstract][Full Text] [Related]
55. Mesenchymal chondrosarcoma of the left coronoid process: report of a unique case with clinical, histopathologic, and immunohistochemical findings, and a review of the literature.
Angiero F; Vinci R; Sidoni A; Stefani M
Quintessence Int; 2007 Apr; 38(4):349-55. PubMed ID: 17432791
[TBL] [Abstract][Full Text] [Related]
56. Mesenchymal chondrosarcoma of the orbit. Report of three new cases and review of the literature.
Jacobs JL; Merriam JC; Chadburn A; Garvin J; Housepian E; Hilal SK
Cancer; 1994 Jan; 73(2):399-405. PubMed ID: 8293407
[TBL] [Abstract][Full Text] [Related]
57. [CIC-rearranged sarcoma:a clinicopathological analysis of 10 cases].
Zhao L; Sun M; Weng QY; Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2019 Jul; 48(7):515-521. PubMed ID: 31288305
[No Abstract] [Full Text] [Related]
58. Mesenchymal chondrosarcoma: a series of 23 cases.
Jambhekar NA; Desai SS; Aggarwal MG; Puri A; Merchant N
Indian J Pathol Microbiol; 2004 Oct; 47(4):491-3. PubMed ID: 16295373
[TBL] [Abstract][Full Text] [Related]
59. NKX3.1 immunoreactivity is not identified in mesenchymal chondrosarcoma: a 25-case cohort study.
Chen W; Hornick JL; Fletcher CDM
Histopathology; 2021 Jan; 78(2):334-337. PubMed ID: 32779239
[TBL] [Abstract][Full Text] [Related]
60. Meningeal mesenchymal chondrosarcoma: report of 8 cases with review of the literature.
Scheithauer BW; Rubinstein LJ
Cancer; 1978 Dec; 42(6):2744-52. PubMed ID: 365318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
